Finch Therapeutics Group Stock Price History

FNCH Stock  USD 2.03  0.32  13.62%   
If you're considering investing in Finch Stock, it is important to understand the factors that can impact its price. As of today, the current price of Finch Therapeutics stands at 2.03, as last reported on the 16th of April 2024, with the highest price reaching 2.41 and the lowest price hitting 1.86 during the day. Finch Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0538, which denotes the company had a -0.0538% return per unit of risk over the last 3 months. Finch Therapeutics Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Finch Therapeutics' Variance of 49.06, mean deviation of 4.29, and Standard Deviation of 7.0 to check the risk estimate we provide.
  
As of now, Finch Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Finch Therapeutics' current Liabilities And Stockholders Equity is estimated to increase to about 116.5 M, while Common Stock Total Equity is projected to decrease to 6,400. . As of now, Finch Therapeutics' Price To Book Ratio is increasing as compared to previous years. The Finch Therapeutics' current Price Sales Ratio is estimated to increase to 75.01, while Price Earnings Ratio is projected to decrease to (0.08). Finch Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0538

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsFNCH

Estimated Market Risk

 7.21
  actual daily
63
63% of assets are less volatile

Expected Return

 -0.39
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Finch Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Finch Therapeutics by adding Finch Therapeutics to a well-diversified portfolio.
Price Book
0.1424
Enterprise Value Ebitda
(0.25)
Price Sales
30.4644
Shares Float
792.9 K
Wall Street Target Price
90

Finch Therapeutics Stock Price History Chart

There are several ways to analyze Finch Stock price data. The simplest method is using a basic Finch candlestick price chart, which shows Finch Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 11, 20243.42
Lowest PriceApril 12, 20242.03

Finch Therapeutics April 16, 2024 Stock Price Synopsis

Various analyses of Finch Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Finch Stock. It can be used to describe the percentage change in the price of Finch Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Finch Stock.
Finch Therapeutics Price Action Indicator(0.27)
Finch Therapeutics Price Rate Of Daily Change 0.86 
Finch Therapeutics Price Daily Balance Of Power(0.58)

Finch Therapeutics April 16, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Finch Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Finch Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Finch Stock and then apply it to test your longer-term investment strategies against Finch.

Finch Stock Price History Data

The price series of Finch Therapeutics for the period between Wed, Jan 17, 2024 and Tue, Apr 16, 2024 has a statistical range of 1.39 with a coefficient of variation of 10.1. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.66. The median price for the last 90 days is 2.61. The company completed 1:30 stock split on 12th of June 2023.
OpenHighLowCloseVolume
04/16/2024
 2.41  2.41  1.86  2.03 
04/12/2024 2.41  2.41  1.86  2.03  33,149 
04/11/2024 2.45  2.45  2.23  2.35  20,765 
04/10/2024 2.45  2.49  2.45  2.45  1,686 
04/09/2024 2.21  2.53  2.14  2.46  23,969 
04/08/2024 2.14  2.32  2.14  2.20  24,481 
04/05/2024 2.36  2.40  2.16  2.20  16,459 
04/04/2024 2.47  2.53  2.15  2.29  20,205 
04/03/2024 2.45  2.49  2.35  2.40  17,917 
04/02/2024 2.50  2.54  2.32  2.46  6,894 
04/01/2024 2.59  2.60  2.50  2.55  3,998 
03/28/2024 2.80  2.86  2.48  2.60  15,848 
03/27/2024 3.16  3.16  2.64  2.89  3,404 
03/26/2024 2.62  2.66  2.50  2.65  2,421 
03/25/2024 2.81  2.81  2.68  2.70  5,246 
03/22/2024 2.64  2.80  2.55  2.57  5,482 
03/21/2024 2.79  2.79  2.61  2.61  8,606 
03/20/2024 2.79  2.79  2.67  2.74  5,208 
03/19/2024 2.51  2.86  2.51  2.79  2,275 
03/18/2024 2.65  2.80  2.55  2.72  15,212 
03/15/2024 2.45  2.56  2.45  2.56  4,242 
03/14/2024 2.52  2.64  2.46  2.50  11,988 
03/13/2024 2.67  2.81  2.42  2.56  26,437 
03/12/2024 3.10  3.10  2.62  2.69  74,358 
03/11/2024 2.59  4.46  2.51  3.42  392,961 
03/08/2024 2.51  2.51  2.37  2.50  1,153 
03/07/2024 2.50  2.51  2.37  2.45  5,574 
03/06/2024 2.40  2.52  2.40  2.50  3,003 
03/05/2024 2.65  2.66  2.35  2.50  4,823 
03/04/2024 2.78  2.84  2.63  2.64  12,386 
03/01/2024 2.70  2.89  2.62  2.72  19,939 
02/29/2024 2.60  2.70  2.48  2.70  2,596 
02/28/2024 2.55  2.72  2.38  2.61  6,023 
02/27/2024 2.43  2.68  2.38  2.54  5,875 
02/26/2024 2.55  2.70  2.42  2.54  16,372 
02/23/2024 2.26  2.53  2.26  2.42  7,345 
02/22/2024 2.42  2.54  2.25  2.31  15,681 
02/21/2024 2.42  2.50  2.42  2.48  1,191 
02/20/2024 2.50  2.67  2.41  2.50  20,860 
02/16/2024 2.41  2.65  2.31  2.50  15,531 
02/15/2024 2.41  2.65  2.19  2.50  19,416 
02/14/2024 2.20  2.58  2.20  2.34  10,734 
02/13/2024 2.42  2.67  2.35  2.54  12,263 
02/12/2024 2.56  2.71  2.56  2.63  1,280 
02/09/2024 2.64  2.64  2.50  2.55  4,631 
02/08/2024 2.56  2.59  2.48  2.59  3,490 
02/07/2024 2.76  2.82  2.57  2.65  5,229 
02/06/2024 2.61  2.81  2.49  2.79  27,708 
02/05/2024 2.52  2.66  2.52  2.56  5,974 
02/02/2024 2.72  2.95  2.51  2.69  20,028 
02/01/2024 2.95  2.95  2.68  2.70  4,869 
01/31/2024 2.70  2.98  2.70  2.75  2,056 
01/30/2024 2.82  2.98  2.81  2.93  3,513 
01/29/2024 2.95  2.97  2.90  2.94  4,380 
01/26/2024 3.13  3.13  2.85  2.90  6,011 
01/25/2024 2.82  3.20  2.82  3.09  4,980 
01/24/2024 2.83  2.89  2.68  2.83  13,907 
01/23/2024 2.99  2.99  2.85  2.96  896.00 
01/22/2024 3.24  3.24  2.80  2.91  4,154 
01/19/2024 2.97  2.97  2.78  2.85  16,067 
01/18/2024 2.94  3.02  2.94  3.01  612.00 

About Finch Therapeutics Stock history

Finch Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Finch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Finch Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Finch Therapeutics stock prices may prove useful in developing a viable investing in Finch Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.6 M1.3 M
Net Loss-103.2 M-98 M

Finch Therapeutics Quarterly Net Working Capital

21.76 Million

Finch Therapeutics Stock Technical Analysis

Finch Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Finch Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Finch Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module

Finch Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Finch Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Finch Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Finch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Finch Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Finch Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Finch Therapeutics Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Finch Therapeutics Group Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Finch Therapeutics Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Finch Therapeutics information on this page should be used as a complementary analysis to other Finch Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Finch Stock analysis

When running Finch Therapeutics' price analysis, check to measure Finch Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Finch Therapeutics is operating at the current time. Most of Finch Therapeutics' value examination focuses on studying past and present price action to predict the probability of Finch Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Finch Therapeutics' price. Additionally, you may evaluate how the addition of Finch Therapeutics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Finch Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Finch Therapeutics. If investors know Finch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Finch Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(46.59)
Revenue Per Share
0.067
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.19)
Return On Equity
(1.26)
The market value of Finch Therapeutics is measured differently than its book value, which is the value of Finch that is recorded on the company's balance sheet. Investors also form their own opinion of Finch Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Finch Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Finch Therapeutics' market value can be influenced by many factors that don't directly affect Finch Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Finch Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Finch Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Finch Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.